{"domain":"qelbree.com","status":"valid","tier":"listed","authority":46,"verified":false,"title":"Qelbree","summary":"Qelbree® (viloxazine extended-release capsules) is a prescription medicine from Supernus Pharmaceuticals, Inc. used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older. Qelbree.com is the U.S. direct-to-consumer (DTC) product website for patients, parents, and caregivers. Healthcare professionals have a separate professional website at QelbreeHCP.com.","country":"US","country_source":"ip","llms_txt":"https://www.qelbree.com/llms.txt","llms_full_txt":null,"last_checked":"2026-10-20T16:03:33.403Z","agent_terms":null,"categories":["healthcare"],"capabilities":[],"inferred_tags":["adhd","viloxazine","adhd medication","pediatric adhd","prescribing information"],"audience":"consumers","agent_uses":["read_docs"],"language":"en","platform_generated":false,"agent_summary":"Direct-to-consumer site for Qelbree (viloxazine) ADHD medication from Supernus, with prescribing information and caregiver education for patients aged 6+.","llms_txt_cached":"https://agentwebmap.com/v1/domain/qelbree.com/llms.txt","agentic":"documentation","section_keys":["about-adhd","about-qelbree","entity","essential-pages","optional-supporting-resources","scope","site-structure","source-priority-and-medical-safety-rules","stories-savings-and-resources","structured-data-and-canonical-interpretation","taking-qelbree"],"section_partial":false,"section_indexed_at":"2026-10-21T14:19:15.864Z"}